News > Govt panel recommends EUA for Covid vaccine Covovax for 12-17 age group

Govt panel recommends EUA for Covid vaccine Covovax for 12-17 age group

Business Insider | 04/03/2022 09:56 PM | Click to read full article

An expert panel of the country's central drug authority has recommended granting emergency use authorisation (EUA) to Serum Institute of India's COVID-19 vaccine Covovax for the 12-17 age group, official sources said on Friday.

Advertisement The Drugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situation in adults on December 28.